The DOI matches its Crossref record.
Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus
Abstract
Implementation of meticillin-resistant Staphylococcus aureus (MRSA) decolonisation programmes has been increasing and the emergence of mupirocin resistance has been reported. However, the patient-level risk factors associated with mupirocin resistance are not clear. In this study, independent predictors of mupirocin resistance in MRSA among Providence Veterans Affairs Medical Center patients with MRSA-positive culture dates between 1 July 2004 and 30 June 2008 were identified using a frequency-matched case-control study. Forty cases (mupirocin-resistant) were matched on culture date quarter and year to 270 controls (mupirocin-susceptible). The adjusted conditional logistic regression model identified three significant independent predictors associated with mupirocin resistance in MRSA: (1) exposure to mupirocin in the year prior to the culture date [odds ratio (OR): 9.84; 95% confidence interval (CI): 2.93-33.09]; (2) Pseudomonas aeruginosa infection in the year before the culture-related admission (4.85; 1.20-19.61); and (3) cefepime use in the year prior to culture (2.80; 1.03-7.58). In sensitivity analyses, previous mupirocin exposure was associated with low-level [minimum inhibitory concentration (MIC) 8-128mg/L; 23 cases, 202 controls; OR: 6.32; 95% CI: 1.58-25.33] and high-level (MIC ≥256mg/L; 17 cases, 151 controls; OR: 11.18; 95% CI: 1.89-66.30) mupirocin resistance. To our knowledge, this is the first case-control study to reveal a strong association between previous mupirocin exposure and subsequent mupirocin resistance in MRSA, with demonstrated robustness in low- and high-level mupirocin resistance. Mupirocin susceptibility monitoring is critical for facilities instituting decolonisation with mupirocin as increased use may reduce effectiveness through resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of the mupA gene conditions the MIC of mupirocin from 500 to >1000 mg/L [159,163,164,165,166].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- Gorwitz, 2008, Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004, J Infect Dis, 197, 1226, 10.1086/533494 · DOI · Paper page
- Klein, 2007, Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005, Emerg Infect Dis, 13, 1840, 10.3201/eid1312.070629 · DOI · Paper page
- Klevens, 2006, Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003, Clin Infect Dis, 42, 389, 10.1086/499367 · DOI · Paper page
- Muto, 2003, SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus, Infect Control Hosp Epidemiol, 24, 362, 10.1086/502213 · doi:10.1086/502213 · Paper page
- Calfee, 2008, Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals, Infect Control Hosp Epidemiol, 29, S62, 10.1086/591061 · DOI · Paper page
- van Rijen, 2008, Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review, J Antimicrob Chemother, 61, 254, 10.1093/jac/dkm480 · DOI · Paper page
- Walker, 2003, Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?, Infect Control Hosp Epidemiol, 24, 342, 10.1086/502218 · DOI
- Robicsek, 2009, Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk, Infect Control Hosp Epidemiol, 30, 623, 10.1086/597550 · DOI
- Kallen, 2005, Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis, Infect Control Hosp Epidemiol, 26, 916, 10.1086/505453 · doi:10.1086/505453
- Ammerlaan, 2009, Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review, Clin Infect Dis, 48, 922, 10.1086/597291 · DOI · Paper page
- Cookson, 1990, Mupirocin-resistant Staphylococcus aureus, Lancet, 335, 1095, 10.1016/0140-6736(90)92667-7 · DOI
- Harbarth, 1999, Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus, Antimicrob Agents Chemother, 43, 1412, 10.1128/AAC.43.6.1412 · DOI · Paper page
- Simor, 2007, Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization, Clin Infect Dis, 44, 178, 10.1086/510392 · DOI · Paper page
- Udo, 2001, Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance, J Med Microbiol, 50, 909, 10.1099/0022-1317-50-10-909 · doi:10.1099/0022-1317-50-10-909
- Yun, 2003, Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital, J Antimicrob Chemother, 51, 619, 10.1093/jac/dkg140 · doi:10.1093/jac/dkg140
- Cookson, 1998, The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice, J Antimicrob Chemother, 41, 11, 10.1093/jac/41.1.11 · doi:10.1093/jac/41.1.11
- Vasquez, 2000, The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans’ Affairs hospital, Infect Control Hosp Epidemiol, 21, 459, 10.1086/501788 · doi:10.1086/501788
- Jones, 2007, Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit, Clin Infect Dis, 45, 541, 10.1086/520663 · DOI
- Simor, 2007, Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals, Antimicrob Agents Chemother, 51, 3880, 10.1128/AAC.00846-07 · DOI · Paper page
- Park, 2007, Risk factors for isolation of low-level mupirocin-resistant versus -susceptible methicillin-resistant Staphylococcus aureus from patients in intensive care units, J Infect, 54, 337, 10.1016/j.jinf.2006.06.008 · doi:10.1016/j.jinf.2006.06.008
- Miller, 1996, Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment, Infect Control Hosp Epidemiol, 17, 811, 10.1086/647242 · doi:10.1086/647242 · Paper page
- Walker, 2004, A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions, J Clin Microbiol, 42, 2792, 10.1128/JCM.42.6.2792-2795.2004 · doi:10.1128/jcm.42.6.2792-2795.2004
- Yanagisawa, 2003, How does Pseudomonas fluorescens avoid suicide from its antibiotic pseudomonic acid? Evidence for two evolutionarily distinct isoleucyl-tRNA synthetases conferring self-defense, J Biol Chem, 278, 25887, 10.1074/jbc.M302633200 · DOI
- Sutherland, 1985, Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use, Antimicrob Agents Chemother, 27, 495, 10.1128/AAC.27.4.495 · doi:10.1128/aac.27.4.495
- Patel, 2009, Mupirocin resistance, Clin Infect Dis, 49, 935, 10.1086/605495 · DOI · Paper page
- Ramsey, 1996, Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates, Antimicrob Agents Chemother, 40, 2820, 10.1128/AAC.40.12.2820 · doi:10.1128/aac.40.12.2820
- Driscoll, 2007, Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism, Antimicrob Agents Chemother, 51, 2247, 10.1128/AAC.00241-07 · DOI
Cited by
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Decolonization in Prevention of Health Care-Associated Infections
Septimus, E. J., & Schweizer, M. L. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-15 · Cited by 259
Tandon, P., DeLisle, A., Topal, J. E., & Garcia–Tsao, G. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.017 · Cited by 158
Metadata
- Authors
- Caffrey, A. R., Quilliam, B. J., & LaPlante, K. L.
- Venue
- Journal of Hospital Infection
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 76
- Issue
- 3
- Pages
- 206-210
- ISSN
- 0195-6701
- Cited by
- 67
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus. https://app.cochat.ai/papers/10.1016/j.jhin.2010.06.023
- The paper
- Caffrey, A. R., Quilliam, B. J., & LaPlante, K. L. (2010). Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus. Journal of Hospital Infection. https://doi.org/10.1016/j.jhin.2010.06.023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.